Business
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits
PharmaPack Program to Expand Access to Affordable, FDA-Approved Branded Ophthalmic TherapiesNASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber (DTP) cash-pay offering called PharmaPack, which expands the Company’s commitment to offering affordable FDA-approved branded products as alternatives to off-label compounded formulations. PharmaP
About this update from Harrow, Inc.
[{"type":"image","alt":"Harrow, Inc.","displaySize":"","headline":null,"caption":"Harrow, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/5c70a4ce2372c78fe8eac93acf26691f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ydPSLlO9mYGzfoj8dx3okA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5c70a4ce2372c78fe8eac93acf26691f","width":300,"height":158}},"lazy":false},{"type":"text","content":"PharmaPack Program to Expand Access to Affordable, FDA-Approved Branded Ophthalmic Therapies","length":92,"tagName":"p"},{"type":"text","content":"NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber (DTP) cash-pay offering called PharmaPack, which expands the Company’s commitment to offering affordable FDA-approved branded products as alternatives to off-label compounded formulations.","length":400,"tagName":"p"},{"type":"text","content":"PharmaPack kits expand access to FDA-approved ophthalmic products for the millions of Americans each year who require infection control and treatment of pain and inflammation associated with cataract surgery. PharmaPack kits also remove insurance-related administrative complexity and reduce regulatory and medical-legal risk associated with off-label compounded products. Harrow will offer the following PharmaPack kits at affordable and 100% transparent pricing:","length":464,"tagName":"p"},{"type":"image","alt":"Harrow Announces PharmaPack™ Kits","displaySize":"","headline":null,"caption":"Harrow Announces PharmaPack™ Kits","className":"","disableSlideshowImg":false,"size":{"original":{"width":624,"height":774,"url":"https://media.zenfs.com/en/globenewswire.com/68765aa93d10652fc18b525388330d0b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IzKVYwRvSdOwwDmM5DS1tg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTExOTE7Y2Y9d2VicA--/https://media.zenfs.com/en/globenewswire.com/68765aa93d10652fc18b525388330d0b","width":624,"height":774}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"“Harrow’s PharmaPack program addresses a long-standing challenge in ophthalmology—providing patients with FDA-approved ...